skip to main content
Idioma:
Refinado por: Nome da Publicação: Retrovirology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa
P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa
Material Type:
Artigo 		Adicionar ao Meu Espaço

P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa

Allen, MA ; Gray, G ; Churchyard, G ; Bekker, L ; Nchabeleng, M ; Mlisana, K ; Metch, B ; Moodie, Z ; Roux, S ; Mathebula, M ; Bennie, T ; Kublin, J

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P190-P190, Article P190 [Periódico revisado por pares]

London: BioMed Central

Texto completo disponível

Citações Citado por
2
P14-07. Offering new prevention modalities in HIV vaccine trials: experience with male circumcision in the Phambili trial
P14-07. Offering new prevention modalities in HIV vaccine trials: experience with male circumcision in the Phambili trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

P14-07. Offering new prevention modalities in HIV vaccine trials: experience with male circumcision in the Phambili trial

de Bruyn, G ; Mlisana, K ; Metch, B ; Churchyard, G ; Nchabeleng, M ; Bekker, L ; Roux, S ; Naicker, N ; Latka, M ; Corey, L ; Kublin, J ; Gray, G

Retrovirology, 2009-10, Vol.6 (S3), p.P195-P195, Article P195 [Periódico revisado por pares]

London: BioMed Central

Texto completo disponível

Citações Citado por
3
P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?
P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?
Material Type:
Artigo 		Adicionar ao Meu Espaço

P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?

Gray, GE ; Bekker, L ; Churchyard, G ; Nchabeleng, M ; Mlisana, K ; de Bruyn, G ; Roux, S ; Mathebula, M ; Latka, M ; Bennie, T ; Metch, B ; Moodie, Z ; Allen, M ; Eaton, N ; Kublin, J

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P209-P209, Article P209 [Periódico revisado por pares]

BioMed Central Ltd

Texto completo disponível

Citações Citado por
4
Feasibility of recruiting high-risk women in the US for HIV vaccine efficacy trials (HVTN 906)
Feasibility of recruiting high-risk women in the US for HIV vaccine efficacy trials (HVTN 906)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Feasibility of recruiting high-risk women in the US for HIV vaccine efficacy trials (HVTN 906)

Koblin, B ; Metch, B ; Morgan, C ; Novak, R ; Swann, E ; Metzger, D ; Lucy, D ; Dunbar, D ; Graham, P ; Madenwald, T ; Escamia, G ; Frank, I

Retrovirology, 2012-09, Vol.9 (S2), p.P123-P123, Article P123 [Periódico revisado por pares]

London: BioMed Central

Texto completo disponível

Citações Citado por
5
DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials
DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials

Morgan, C ; Jin, X ; Yu, X ; De Rosa, S ; Kublin, J ; Metch, B ; Keefer, M ; NIAID, H

Retrovirology, 2012-09, Vol.9 (S2), p.P133-P133, Article P133 [Periódico revisado por pares]

London: BioMed Central

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.